SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
5.48
+0.20 (3.79%)
Apr 30, 2026, 10:49 AM EDT - Market open
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $392.74 million as of April 30, 2026. Its market cap has increased by 103.35% in one year.
Market Cap
392.74M
Enterprise Value
376.16M
1-Year Change
103.35%
Ranking
Category
Stock Price
$5.48
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $392.74M, a decrease of -64.94%. That is a compound annual growth rate of -19.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 379.13M | 19.66% |
| Dec 31, 2025 | 316.85M | 55.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phreesia | 587.58M |
| Claritev | 402.89M |
| National Research | 392.49M |
| Weave Communications | 385.77M |
| Evolent Health | 382.92M |
| TruBridge | 372.12M |
| Simulations Plus | 298.23M |
| Carlsmed | 275.59M |